Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Scapozza

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Molecules (Basel, Switzerland)|June 18, 2020
How 'Protein-Docking' Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?Francesca Tessaro, Leonardo Scapozza
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2020
Exploiting the gut microbiota's fermentation capabilities towards disease preventionThomas Gurry, Leonardo Scapozza
Chimia|December 9, 2023
Linkers as Game-changers in PROTAC Technology: Emphasizing General Trends in PROTAC Pharmacokinetics for their Rational DesignCarlotta Cecchini, Sébastien Tardy, Leonardo Scapozza
Methods (San Diego, Calif.)|September 7, 2014
Virtual screening: an in silico tool for interlacing the chemical universe with the proteomeYvonne Westermaier, Xavier Barril, Leonardo Scapozza
Journal of Receptor and Signal Transduction Research|September 4, 2004
Thermodynamics of protein-ligand interactions: history, presence, and future aspectsRemo Perozzo, Gerd Folkers, Leonardo Scapozza
Chimia|August 8, 2012
The pharmaceutical biochemistry group: where pharmaceutical chemistry meets biology and drug deliveryYogeshvar N Kalia, Remo Perozzo, Leonardo Scapozza
Frontiers in Chemistry|May 7, 2021
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein DegradationCarlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, et al.
Journal of Receptor and Signal Transduction Research|February 3, 2004
Tautomerism in computer-aided drug designPavel Pospisil, Patrick Ballmer, Leonardo Scapozza, et al.
Pharmaceutical Research|February 16, 2013
Breaking the aggregation of the monoclonal antibody bevacizumab (avastin®) by dexamethasone phosphate: insights from molecular modelling and asymmetrical flow field-flow fractionationMarieke Veurink, Yvonne Westermaier, Robert Gurny, et al.
Journal of Receptor and Signal Transduction Research|December 31, 2002
Methodology and problems of protein-ligand docking: case study of dihydroorotate dehydrogenase, thymidine kinase, and phosphodiesterase 4Pavel Pospisil, Thomas Kuoni, Leonardo Scapozza, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Molecules (Basel, Switzerland)|June 18, 2020
How 'Protein-Docking' Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?Francesca Tessaro, Leonardo Scapozza
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2020
Exploiting the gut microbiota's fermentation capabilities towards disease preventionThomas Gurry, Leonardo Scapozza
Chimia|December 9, 2023
Linkers as Game-changers in PROTAC Technology: Emphasizing General Trends in PROTAC Pharmacokinetics for their Rational DesignCarlotta Cecchini, Sébastien Tardy, Leonardo Scapozza
Methods (San Diego, Calif.)|September 7, 2014
Virtual screening: an in silico tool for interlacing the chemical universe with the proteomeYvonne Westermaier, Xavier Barril, Leonardo Scapozza
Journal of Receptor and Signal Transduction Research|September 4, 2004
Thermodynamics of protein-ligand interactions: history, presence, and future aspectsRemo Perozzo, Gerd Folkers, Leonardo Scapozza
Chimia|August 8, 2012
The pharmaceutical biochemistry group: where pharmaceutical chemistry meets biology and drug deliveryYogeshvar N Kalia, Remo Perozzo, Leonardo Scapozza
Frontiers in Chemistry|May 7, 2021
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein DegradationCarlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, et al.
Journal of Receptor and Signal Transduction Research|February 3, 2004
Tautomerism in computer-aided drug designPavel Pospisil, Patrick Ballmer, Leonardo Scapozza, et al.
Pharmaceutical Research|February 16, 2013
Breaking the aggregation of the monoclonal antibody bevacizumab (avastin®) by dexamethasone phosphate: insights from molecular modelling and asymmetrical flow field-flow fractionationMarieke Veurink, Yvonne Westermaier, Robert Gurny, et al.
Journal of Receptor and Signal Transduction Research|December 31, 2002
Methodology and problems of protein-ligand docking: case study of dihydroorotate dehydrogenase, thymidine kinase, and phosphodiesterase 4Pavel Pospisil, Thomas Kuoni, Leonardo Scapozza, et al.
Pageof 14